Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation

<div>Trends in average HCYS blood levels and PASI scores at four time points in psoriatic patient subgroups with normal and elevated HCYS level. <i>Abbreviations.</i> HCYS: homocysteine; PASI: Psoriasis Area Severity Index.</div>

International Journal of Clinical Practice

fig2

Figure 2

Figure 2: Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation 

Figure 2 | Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation 